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'atural  Killer  (NK)  cells  are  cytotoxic  lymphocytes 
that, in the absence of prior stimulation, lyse a variety 
of target cells, including tumor cells, virus-, or intracdlular 
bacteria-infected cells,  and, in some cases, normal cells (1). 
Thus, NK cells represent a first line of defense to infections, 
tumor  growth,  or  other  pathogenic  alterations  of tissue 
homeostasis. Unlike T  or B lymphocytes, NK cells do not 
express molecularly rearranged receptors and, in particular, 
neither rearrange nor express on their surface any of the four 
genes encoding the T cell receptor (TCR). Activation of NK 
cells results not only in cytotoxicity but also in rapid secre- 
tion of cytokines, particularly interferon-7 (IFN-3`), granulo- 
cyte/macrophage colony-stimulatory factor (GM-CSF), and 
tumor necrosis factor (TNF) (1). The ability of NK cells to 
recognize  and  destroy  target  cells  has  been  considered 
nonspecific and possibly mediated by multiple adhesionlike 
receptors recognizing an altered pattern of expression of sur- 
face molecules on pathological target cells. 
The best characterized receptor able to activate NK cell 
cytotoxicity and cytokine production is the receptor for Fc 
of IgG type IliA (Fc3`RIIIA or CD16).  CD16 is associated 
with dimers of the ~" chain of CD3/TCR or of the 3' chain 
of FceRI,  and  mediates  signal  transduction  with  similar 
mechanisms as those observed via the TCR/CD3 complex 
(1). Through CD16, NK cells recognize IgG antibody-coated 
target  cells  and  mediate  antibody-dependent  cytotoxicity 
(ADCC).  However,  CD16 does not appear to be involved 
in the induction of cytotoxicity in the absence of antibodies 
(1). Other cytotoxicity-triggering receptors have been described 
on NK cells, but their ligands on target cells and their role 
in cytotoxicity have not been elucidated. 
Although the activity of NK  cells  has been considered 
nonspecific  and,  unlike  CD8 §  cytotoxic  T  lymphocytes 
(CTL), does not require the expression of major histocom- 
patibility complex (MHC) antigens on target cells, evidence 
suggesting specificity in NK cell recognition has been ac- 
cumulating for many years. Kiessling et al. (2) demonstrated 
that NK cells were the effector cells responsible for the rejec- 
tion of parental bone marrow grafts in irradiated F1 mice 
(hematopoietic hybrid resistance) indicating a genetic specificity 
in  NK  cell  action.  The  major  locus  responsible  for  this 
resistance, Hh-1, was mapped to the H-2DL region and studies 
with  H-2D a transgenic  mice strongly  suggested that  the 
product  of  the  class  I  allele  D d is  a  major  determinant 
governing the genetic specificity of NK cells (3). In rats, NK 
cells rapidly eliminate in vivo allogeneic lymphocytes as well 
as bone marrow cells (allogeneic lymphocyte cytotoxicity, 
ALC), and aUoreactive NK calls were also generated in vitro 
(4). The genetic dements controlling this alloreactivity are 
in a dass I region (RT1-C) of the rat MHC, but, unlike rou- 
tine hybrid resistance in which the susceptibility to rejection 
was always inherited as a recessive trait (and resistance as a 
dominant one), susceptibility to both rejection and lysis by 
rat alloreactive NK cells was found to segregate dominantly, 
although rarely,  in some strain combinations (4). 
In several experimental systems, the susceptibility of target 
cells  to NK call-mediated lysis is inversely proportional to 
their expression of class  I MHC  antigens (5).  One of the 
hypotheses to explain the ability of NK cells to recognize 
class I low target cells is the "missing self hypothesis" that 
postulates that one function of NK cells is to recognize and 
eliminate cells that do not express MHC class  I molecules 
(5).  This hypothesis needs to be modified, however, to ac- 
commodate findings suggesting that NK cells may be affected 
not only by the presence or absence of class I molecules, but 
also by the nature of MHC-bound peptide fitting, either be- 
cause, similarly to T cells, they might directly sense the com- 
bination  of peptide and MHC,  or because they recognize 
changes in molecular conformations of the MHC molecules 
induced by the peptide binding (6). The peptide-binding class 
I o~1/o~2 domains have been shown to be necessary for NK 
cell recognition, and single amino acid substitutions in the 
peptide-binding groove of the class I molecules alter the ability 
of the molecules to protect target cdls from NK cells  (6). 
It has also been suggested that alteration of endogenous pep- 
tides by external peptide loading or by virus infection abrogates 
class I-mediated resistance of target cells and makes them sus- 
ceptible to NK  cdl cytotoxicity (7). 
Two hypotheses have been proposed to explain the mecha- 
nism of dass I recognition by NK cells: (a) the effector inhi- 
bition hypothesis postulating that the presence of class I (or 
particular conformations of class I) on the target ceUs ddivers 
a negative signal to the NK cells, which prevents the activa- 
tion of cytotoxicity; or (b) the target interference hypothesis 
postulating that class I antigens or their peptides sterically 
mask recognition of an NK  target  structure on the target 
cells (5). Although many of the experimental data can be ex- 
plained on the basis of either hypothesis, or through inter- 
mediate interpretations, several recent lines of evidence, dis- 
cussed below, appear to favor the effector inhibition hypothesis. 
The first receptor identified on murine NK  cells  that is 
probably involved in recognition of class I MHC is the Ly-49 
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mice (8). Both the Ly-49 + and Ly-49-  subsets of NK cells 
have similar cytotoxic activity against NK-sensitive cell lines, 
but the Ly-49 + subset, unlike the Ly-49-  one, is unable to 
lyse target cells  expressing H-2D a or H-2D k (8).  The fol- 
lowing observations suggest that interaction of Ly-49 with 
class I MHC D a or D k delivers a negative signal to the NK 
cells: (a) anti-Ly-49 or anti-class I o~1/ot2 domain antibodies 
restore lysis of H-2D a or D k target cells by Ly-49 + NK cells 
(8); (b) Ly-49 + cells bind to purified D a or D k molecules and 
this binding is prevented by anti-Ly-49 antibodies (9);  and 
(c) the Ly-49 + NK cells binding to a H-2D d or D k target 
cell are globally inactivated and can not mediate ADCC against 
the same target cells (8). Ly-49 is a homodimeric type II in- 
tegral membrane protein with COOH-terminal extracellular 
domains homologous to members of the C-type lectin su- 
perfamily. In addition to the Ly-49 gene, there are several 
genes highly homologous to Ly-49  (10)  that may encode 
receptors recognizing dass I antigens, possibly with a different 
specificity, and account for the class I-mediated protection 
of target cells against the majority of NK cells which are 
Ly-49-  (10).  The Ly-49 multigene family is encoded by a 
cluster of genes, the NK gene complex, which are in the distal 
portion of mouse chromosome 6, associated with the genes 
encoding the NKI.1, NKK-P1, and CD69 antigens, which 
are all disulfide-linked dimers of type II integral membrane 
proteins with type C lectin homology (10). The human CD69 
antigen is encoded by a gene in the chromosome 12p13 near 
the NKG2 gene cluster, encoding other still uncharacterized 
type II integral membrane molecules preferentially expressed 
in NK cells (10).  Although these lectinlike molecules have 
a specificity for carbohydrates, they might also bind to poly- 
peptide or conformational sequences, as shown by the fact 
that CD23, one of the members of this family, binds to IgE 
independently of carbohydrates, whereas it binds to the car- 
bohydrate structure of CD21 (11). It is noteworthy that many 
members of this receptor family, e.g., NKI-1, NKK-P1, and 
CD69, are triggering molecules on NK cells, inducing cyto- 
toxicity  and cytokine production  (10).  Thus,  structurally 
similar molecules are responsible for negative or positive sig- 
naling upon ligand interactions.  Although the ligands for 
NKI.1, NKR-P1,  and CD69 are not known, it can not be 
excluded that they also recognize class I MHC and that in- 
teraction of different NK receptors with class I or of the same 
receptor with different conformations of dass I might de- 
liver either blocking or triggering signals. The data from al- 
loreactive rat NK cells (4), indicating that in certain strain 
combinations the susceptibility to lysis by NK cells cosegre- 
gates with MHC class I in a dominant way, indeed suggest 
the possibility that at least in some instances NK cell cyto- 
toxicity may be activated by direct recognition of class I MHC. 
Because the NK receptors recognizing class I appear to be 
clonally distributed or  at  least  clonally heterogenous,  the 
studies using polydonal NK  cell preparations  are only of 
limited value for the analysis of NK cell specificity. Moretta 
et al.  (12) have extensively analyzed the ability of NK cell 
clones to lyse allogeneic normal cells (PHA blasts). A small 
proportion of CD3-  human NK  clones was found to be 
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cytotoxic for PHA blasts from certain allogeneic donors. Five 
different specificity groups were defined, and for most of them 
the character resistance to lysis dominantly cosegrcgated within 
families with the HLA complex, whereas susceptibility to 
lysis segregated recessively (12).  These findings, which are 
reminiscent of the genetic control of hybrid resistance in mice, 
suggested that single HLA class  I antigens are responsible 
for conferring resistance to the NK cells in a clone specific 
fashion. Moreover, experiments of transfection of class I genes 
in mouse target cells or in class I-deficient human cells demon- 
st'rated that the expression of HLA-Cw3 or Cw4 confers target 
cell resistance to group 2 (specificity NK2)  or to group  1 
NK clones (specificity NK1), respectively (12).  Colonna et 
al.  (13) demonstrated that NKl-specific NK cell clones are 
inhibited by the presence on the target cells of HLA-C alleles 
encoding Asn-77-Lys-80 (including HLA-Cw4, -Cw5, and 
-Cw6), whereas NK2-specific NK cell clones are inhibited 
by HLA-C alleles encoding Ser-77-Asn-80 (including HLA- 
Cwl,  -Cw3,  -Cw7,  and  -Cw13).  Thus,  alloreactive NK 
clones, unlike T cells, do not recognize fine differences among 
highly polymorphic HLA alleles, but rather supertypic (public) 
differences  shared  by  several  alleles.  The  fact  that  NK- 
recognized haplotypes correspond to ancestral haplotypes (14) 
may indicate that the class I recognition mechanisms of NK 
cells precedes evolutionarily the more finely tuned recogni- 
tion mechanism of T  cells.  The analogy with other class I 
molecules suggests that amino acid positions 77 and 80 in 
HLA-C are in the peptide-binding cleft, implicating again 
MHC-bound  peptides in NK cell recognition. 
Putative NK cell receptors for HLA-C  are identified by 
two monodonal antibodies, GL183 and EB6,  that identify 
four subsets of NK cells and react with similar but distinct 
molecules of 55-58 kD on the NK cell surface, most prob- 
ably forming noncovalently linked hetero- or homodimers 
(15). The existence of other members of this family, defined 
p58, possibly able to form dimers with GL183 or EB6, is 
suggested by immunoprecipitation experiments with anti- 
bodies recognizing common determinants of the p58 family. 
Several lines of evidence suggest that the p58 molecules might 
represent receptors for class I HLA-C on NK cells (15). The 
specificity of alloreactive NK clones is closely correlated with 
their  p58  phenotype.  In  particular,  virtually  all  group  1 
specificity  clones  (unable  to  lyse  Cw4 +  target  cells)  are 
EB6 + GL183-,  whereas the group 2 clones (unable to lyse 
Cw3 +  target  cells)  are EB6 +  GL183 +.  Similar  to Ly-49, 
both the EB6 and GL183 antibodies restore lysis of Cw3 + 
cells by group 2 NK clones and the EB6 antibody restores 
lysis of Cw4 + cells by group 1 NK clones (15).  Further- 
more, when the IgG anti-p58 antibodies are added in a lytic 
assay using p58 + NK clones and FcK + murine P815 target 
cells, inhibition of lysis is observed (15).  The interpretation 
of these results is that the anti-p58 antibodies in soluble form 
block the interaction of p58 with HLA-C and prevent delivery 
of a negative signal, whereas, when cross-linked by the FcK 
on the target cells, they inhibit lysis by delivering a negative 
signal, analogous to that delivered upon interaction of p58 
with the HLA-C ligand. The heterodimer EB6/GL183 would 
be a receptor for a group of HLA-C molecules including Cw3, whereas a dimer of EB6 with another member of the p58 
family (or possibly a homodimer) would be a receptor for 
a group of HLA-C  molecules including Cw4  (12).  Other 
p58 molecules could be specific for other class I molecules. 
Unlike the Ly-49 molecules, direct binding of p58 to HLA 
class I molecules to fully support this interpretation remains 
to be demonstrated. 
It is surprising that molecules different in structure from 
Ly-49 have quite similar functions. Unlike Ly-49,  the p58 
molecules do not form covalently linked homodimers and 
they are linked to dimers of either the ~" chain of CD3 or 
the 3' chain of Fc~RI and are associated with the protein tyro- 
sine kinase p56 lck. Although cross-linking of p58 induced a 
Ca  2+ flux, in contrast to CD3/TCR  or CD16  triggering, 
phosphorylation of the associated CD3 ~" chain was not ob- 
served (12 and Moretta, A., personal communication). The 
putative negative signal delivered by p58 is reminiscent of 
that observed with Ly-49 in that not only is the lysis of the 
target cells carrying the appropriate class I molecule prevented, 
but a global inactivation of the NK cells is observed as mea- 
sured by an inability to mediate ADCC or antibody-redirected 
lysis against the same target cells (15).  However, this inacti- 
vation is directional, because susceptible target cells are lysed 
in the presence of cold target cells carrying the protective 
class  I molecules (15). 
Analysis of alloreactive NK cells for their ability to lyse 
PHA blasts identified only a limited number of doneg whereas 
the large majority of dones appeared not to have allospecifidty. 
However, by analyzing the ability of individual HLA-A, -B, 
or -C molecules transfected into class I negative target cells 
to protect them from lysis mediated by unselected human 
NK clones, Litwin et al. (16) showed that the large majority 
of clones recognize multiple HLA-A,  -B,  or -C alleles,  of 
both autologous and allogeneic origin, and that simple pat- 
terns of recognition were difficult to identify. These results, 
which are reminiscent of the earlier results with polyclonal 
NK cells, suggest that the receptor for class  I antigens on 
NK cells have broad specificity and are heterogeneously dis- 
tributed at the donal level, so that each clone may express 
more than one receptor type in different combinations. Be- 
cause PHA blasts express all six HLA-A, -B, and -C alleles 
and each one of them might react with class I receptors with 
broad specificity on NK cells, clones able to lyse allogeneic 
PHA blasts are rare and characterized by the expression of 
only one or a very limited number of receptors for class I. 
Thus, these alloreactive NK cell clones, unlike the majority 
of NK clones with possible multiple receptors, display simple 
patterns of target specificity, including the reactivity of two 
out of five specificity groups specifically with certain HLA-C 
molecules (12). 
The study of NK clones lyric for allogeneic PHA blasts 
represented a useful tool for defining the characteristics of 
class  I protection of target cells at the clonal level and for 
identifying at least some of the NK cell receptors for HLA-C 
molecules (12). It remained, however, to identify the receptors 
for HLA-A and -B and to determine their contribution to 
the specificity of NK cells both at the clonal and polyclonal 
level. Two papers in this issue of The Journal of Experimental 
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Medicine, by Moretta et al. (17) and by Litwin et al. (18) identify 
the putative receptors on NK cells for two distinct groups 
of HLA-B alleles;  surprisingly, these two receptors are not 
only molecularly different from the p58 receptor for HLA-C, 
but are also quite different among themselves. Moretta et al. 
(17)  identify Kp43  (CD94),  a homodimeric molecule be- 
longing to the family of type II lectinlike transmembrane 
proteins, as the receptor on NK clones responsible for target 
cell protection induced by HLA-B7, -B8, and -B14. Although 
Kp43 is expressed on all NK clones at least at low density 
and was previously characterized as a marker of both resting 
and activated NK cells,  it is expressed at high density only 
on those NK clones that are inactivated by the presence of 
HLA-B7  on  target  cells  (17).  Similar to other  antidass  I 
receptor antibodies, the anti-Kp43 antibody in soluble form 
restores lysis of HLA-B7 + target cells by the Kp43  hish NK 
clones,  whereas  when  IgG  antibodies  are cross-linked on 
FcR + target cells, the spontaneous as well as the antibody- 
dependent cytotoxicity of Kp43hig  h NK clones is blocked, 
suggesting that the Kp43 molecule in this condition delivers 
a negative signal (17). Litwin et al. (18) characterize a single 
chain glycoprotein of 70 kD (NKB1, recognized by antibody 
DX9) that appears to be the NK receptor for the HLA-B*5101, 
-B'5801, and -B'2705, but not for HLA-B7 or any HLA-A 
or -C allde tested. The DX9 antibody restored the ability 
of NKB1 + NK clones to lyse target cells expressing the rele- 
vant HLA-B antigens, suggesting that NKB1,  similarly to 
Kp43, p58, or Ly-49, recognizes class I molecules and delivers 
a negative signal preventing lysis (18). It is of interest to note 
that the alleles recognized by the Kp43 receptor express the 
supertypic specifidty Bw6 whereas those recognized by NKB1 
the supertypic specificity Bw4 (17,  18). It is therefore likely 
that, as in the case for the receptors for HLA-C, the receptor 
for HLA-B on NK cells also recognizes a public and prob- 
ably primordial polymorphism on the dass I molecules and 
not the fine polymorphic differences detected by antibodies 
or T  cells. 
Although the receptors for every class I molecule on NK 
cells have not been identified, the present evidence suggests 
that NK cells, rather than using somatic gene recombination 
for generating receptor diversity, have used receptors of quite 
different molecular structure for developing a relatively re- 
stricted repertoire of specificity for class I, with similar bio- 
logical effects upon ligand interaction. This convergent evo- 
lution in specificity and function of different receptors involves 
possibly primitive lectinlike molecules (Ly-49 and Kp43), het- 
erodimers associated with the CD3 ~" homodimers (p58) that 
are reminiscent of the TCR/CD3 complex, and the still poorly 
characterized  NKB1  70-kD glycoprotein. 
Little is known of the mechanism of the putative negative 
signaling.  In most cases,  the inhibition of cytotoxicity ap- 
pears to be global, with inactivation of both spontaneous and 
antibody-dependent cytotoxicity, but also directional, because 
lysis of a third party target cell is not affected (8, 15, 17, 18). 
The negative signal does not prevent NK-target cell adhe- 
sion and early signals such as Ca  z+ flux or formation of ino- 
sitol phosphates (19). Therefore, the lateral signaling resulting 
in  membrane  molecule modification  and  adhesion  is  not prevented, whereas the vertical signaling, leading to granule 
secretion and cytotoxicity is blocked. These effects appear anal- 
ogous to those initiated by class I or class II antagonistic pep- 
tides that also determine a directional partial inactivation of 
TCR signaling with abrogation of cytotoxicity or prolifera- 
tion, but only partial inhibition of early signaling and no 
effect on binding (20).  However, in the case of antagonistic 
peptides, both the positive and putative negative signaling 
are primarily mediated by the TCR,  whereas in NK cells 
the inhibitory and the triggering receptors may, but not neces- 
sarily, be different molecules. It is also possible that the negative 
signal may depend on alternative signal transduction pathways 
interfering with the cytotoxicity triggering pathway: e.g., 
antibody-induced cross-linking of the CD27 molecule inhibits 
T cell proliferation and NK cell cytotoxicity presumably by 
increasing intracellular cAMP levels (21). 
NK cells may be selectively expanded or deleted during 
differentiation to avoid the presence of autoreactive NK cells. 
NK cell clones are not lytic for autologous normal cells, prob- 
ably because they carry receptors for at least one autologous 
class I allele, as indicated by the ability of certain anti-HLA 
class I antibodies to restore the lysis of autologous normal 
target cells (22).  Therefore, it is likely that NK clones that 
do not have a receptor for at least one autologous class I al- 
lele are eliminated or inactivated during differentiation to pre- 
vent the presence of autoreactive NK cells in vivo. Cells from 
32-microglobulin-deficient mice, which do not express com- 
plete class I MHC antigens, are particularly sensitive to NK 
cell-mediated lysis, both in vitro and in vivo; NK cells from 
these animals have a strongly reduced lytic activity, although 
they are not reduced in number or in their ability to produce 
cytokines, suggesting that NK cells might be subjected to 
negative selection mechanisms (23). However, because of the 
broad specificity of the class I receptor and the presence of 
multiple receptors on NK cells, only a small proportion of 
NK cells are expected to be autoreactive; these few cells may 
not represent a significant risk for the organism, because upon 
interaction with target cells, NK cell cytotoxicity and prolifer- 
ation are rapidly downregulated (1). The presence of receptors 
for autologous class I on NK cells would prevent this down- 
regulation maintaining their cytotoxic potential and allowing 
them to expand in response to appropriate stimuli. The best 
evidence for negative selection of NK cell clones is that the 
EB6 +  GL183-  subset,  which recognizes Cw4,  is  almost 
completely absent from individuals negative for the protec- 
tive HLA-C alleles and thus susceptible to the lysis mediated 
by the EB6 + GL183-  NK cells (15). The interpretation of 
these data is not simple,  because most of the EB6 § GL183- 
NK cells probably also express other receptors for HLA-A 
or -B alleles, that should have allowed them to escape dele- 
tion. The distribution of Ly-49 is also paradoxical; Ly-49 is 
present in ~20%  of NK cells in C57BL/6 mice, which do 
not express the protective D a or D k alleles, whereas it is ab- 
sent in H-2  a or H-2  k strains,  in which Ly-49 prevents au- 
tologous cell lysis (8). Recent studies (24), however, showed 
that Ly-49 is expressed on NK cells from H-2  a or H-2  k mice, 
although at a density ~fivefold lower than in C57BL/6 mice. 
The physiological importance of the class I receptor on 
NK cells is probably not the need to avoid lysis of autolo- 
gous cells or to recognize missing self, a task that could have 
been accomplished with  a much simpler receptor system. 
Rather, the presence of receptors on each NK cell clone, able 
to recognize both autologous and allogeneic class I alleles, 
suggests that NK cells might be poised to recognize major 
changes in conformation of class I antigens, which may take 
place, e.g., during infection by viruses or other intracellular 
pathogens. Because NK cells recognize class I alleles and do 
not  need class  II-restricted helper T  cells  or  professional 
antigen-presenting cells, they might be able to detect patho- 
logical alteration in most tissue cells,  including at least all 
hematopoietic cells and endothelial cells.  Importantly, the 
negative signal mediated by class I receptors prevents both 
cytotoxicity and cytokine production by NK cells (25). Thus, 
activation of NK cells in the absence of negative signals may 
result in both cytotoxicity of the altered tissue cells and produc- 
tion of cytokines. IFN-3, and GM-CSF, produced by NK cells, 
are potent activators of phagocytic cells, contributing to the 
inflammatory processes and making the NK cells an impor- 
tant component of the primordial mechanisms of innate re- 
sistance (1). The same cytokines are also strong activators of 
antigen-presenting cells, by upregulating MHC class II and 
costimulatory molecules. The early NK cell response during 
infection has profound effects on the characteristics of the 
ensuing antigen-specific adaptive immune response, and it 
is required for optimal response of type I T helper cells (26). 
Thus, NK cells appear to have evolved to play an important 
role in modulating the antigen-specific adaptive response of 
helper and cytotoxic T cells (26). It should also be noted that 
several of the receptors expressed on NK cells are expressed 
on some T  cells, often on subsets  of CD8 + cells, with dis- 
tinct functions or cytokine production patterns. Whether some 
of these receptors play a functional role in T  cell functions 
remains to be investigated. 
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